Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Actinium Pharmaceuticals
Company

Actinium Pharmaceuticals

Tracked across 1 events · 7 articles · First seen Mar 28, 2025 · Last active May 29, 2026

Sentiment
50
Attention
2
Events
1
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 50
Business
Actinium Pharmaceuticals receives Canadian patent allowances
Impact: Actinium Pharmaceuticals received two patent allowances from the Canada — Canadian Intellectual Property Office, strengthening its intellectual property protection for its Actimab-A and Iomab-ACT programs. This enhances the company's market position and potential for future revenue.
May 29, 2026 · 7 articles
Relationships (2)
United States — Food and Drug Administration ↔ Actinium Pharmaceuticals
United States — Food and Drug Administration ↔ Actinium Pharmaceuticals
ERGEN INTELLIGENCE
Track Actinium Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.